Infectious Complications of DiGeorge Syndrome in the Setting of Malignancy.

22q11.2 deletion syndrome digeorge syndrome hodgkin’s lymphoma immunodeficiency infectious disease lymphopenia t-cell deficiency

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jun 2022
Historique:
accepted: 24 06 2022
entrez: 28 7 2022
pubmed: 29 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

This report describes a case of a young man with DiGeorge Syndrome, repaired Tetralogy of Fallot, relapsed metastatic Hodgkin's Lymphoma, immunodeficiency, and a history of recurrent and severe infections. A review of the literature indicates that patients with DiGeorge Syndrome are at greater risk for infection, malignancy, and cardiac events due to anatomic and immunologic complications resulting from a deletion in the 22q11.2 chromosome. As an increased number of patients with DiGeorge Syndrome are surviving into adulthood, it is important to understand the progression of the disease and the long-term implications associated with variable degrees of thymic hypoplasia and immune deficiency.

Identifiants

pubmed: 35898360
doi: 10.7759/cureus.26277
pmc: PMC9308940
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e26277

Informations de copyright

Copyright © 2022, Hare et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Clin Dev Immunol. 2006 Jun-Dec;13(2-4):261-4
pubmed: 17162366
Clinics (Sao Paulo). 2010;65(9):865-9
pubmed: 21049214
Arch Immunol Ther Exp (Warsz). 2014 Oct;62(5):385-94
pubmed: 24509696
J Paediatr Child Health. 2006 Jul-Aug;42(7-8):469-71
pubmed: 16898887
Am J Med Genet A. 2017 Sep;173(9):2366-2372
pubmed: 28627729
Am J Med Genet A. 2006 Apr 15;140(8):906-9
pubmed: 16532473
Pediatr Pulmonol. 1997 Nov;24(5):324-30
pubmed: 9407565
Clin Case Rep. 2017 Mar 02;5(4):486-490
pubmed: 28396774
Genet Med. 2015 Aug;17(8):599-609
pubmed: 25569435
Curr Allergy Asthma Rep. 2018 Oct 30;18(12):75
pubmed: 30377837
Intern Med. 2012;51(4):377-80
pubmed: 22333372
Genet Med. 2019 Oct;21(10):2328-2335
pubmed: 30948858
Blood. 2019 Jun 13;133(24):2586-2596
pubmed: 31015189
J Am Heart Assoc. 2020 Dec;9(23):e017580
pubmed: 33196343
J Pediatr Hematol Oncol. 2022 Apr 1;44(3):e819-e822
pubmed: 34966099
J Clin Immunol. 2017 May;37(4):375-382
pubmed: 28429103
Am J Med Genet A. 2018 Oct;176(10):2082-2086
pubmed: 29341423
J Pediatric Infect Dis Soc. 2018 Feb 19;7(1):e6-e8
pubmed: 29040661
Surgery. 2002 Jun;131(6):685-6
pubmed: 12075186
J Clin Immunol. 2015 Jul;35(5):435-8
pubmed: 26048260

Auteurs

Heather Hare (H)

College of Pharmacy, University of Florida Health, Tampa, USA.

Pragya Tiwari (P)

Cardiology, Hridaya Clinic, Delhi, IND.

Aliyah Baluch (A)

Infectious Diseases, Moffitt Cancer Center, Tampa, USA.

John Greene (J)

Internal Medicine, Moffitt Cancer Center, Tampa, USA.

Classifications MeSH